RT Journal Article
ID 1a5c5f2936a724f3
A1 Rong, Libin
A1 Perelson, Alan S.
T1 Treatment of Hepatitis C Virus Infection With Interferon and Small Molecule Direct Antivirals: Viral Kinetics and Modeling
JF Critical Reviews™ in Immunology
JO CRI
YR 2010
FD 2010-04-02
VO 30
IS 2
SP 131
OP 148
K1 virus dynamics
K1 interferon
K1 ribavirin
K1 small molecule inhibitors
K1 drug resistance
K1 combination therapy
AB Hepatitis C virus (HCV) infection remains a threat to global public health. Treatment with pegylated interferon (IFN) plus ribavirin leads to a sustained virologic response in about 50% of patients. New therapies using direct antiviral agents have the potential to cure patients unresponsive to IFN-based therapies. Mathematical modeling has played an important role in studying HCV kinetics. Using models, one can evaluate the effectiveness of new treatment agents, estimate important parameters that govern virus-host interactions, explore possible mechanisms of drug action against HCV, investigate the development of drug resistance, and study quasispecies dynamics during therapy. Here we review our current knowledge of HCV kinetics under IFN-based therapy and newly developed antiviral agents specifically targeted to attack HCV, and show how mathematical models have helped to improve our understanding of HCV infection and treatment.
PB Begell House
LK https://www.dl.begellhouse.com/journals/2ff21abf44b19838,5603dbb41ca52347,1a5c5f2936a724f3.html